Article
Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction…
bioRxiv: the preprint server for biology · 2020 · Matthew D. Beasley, author Sanja Aracic, author Fiona M. Gracey, author Ruban Kannan, author Avisa Masarati, author S. R. Premaratne, author Madhara Udawela, author Rebecca E. Wood, author Shereen Jabar, author Nicole L. Church, author Thien-Kim Le, author Dahna Makris, author Bradley K. McColl, author Ben R. Kiefel, author
Key facts
| Title | Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction isolated from synthetic single-chain antibody libraries |
|---|---|
| First author | Matthew D. Beasley, author Sanja Aracic, author Fiona M. Gracey, author Ruban Kannan, author Avisa Masarati, author S. R. Premaratne, author Madhara Udawela, author Rebecca E. Wood, author Shereen Jabar, author Nicole L. Church, author Thien-Kim Le, author Dahna Makris, author Bradley K. McColl, author Ben R. Kiefel, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Aug 15, 2020 |
| DOI | 10.1101/2020.07.27.224089 |
| Devices mentioned | K042152, K073490, K940422, K982100 |
| Product codes mentioned | CFN, DFZ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1